Interim data from Spineart’s Baguera-C investigational device study found the disc, in two-level cases, meets the threshold for a non-inferiority claim against the study control, according to an April ...

Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim ...

Spineart and eCential Roboticsannounce FDA clearance of PERLA® App for use with Op.n TM robotic navigation platform Dallas, Texas and Franklin, Tennessee, March 13, 2025 — Spineart, a fast ...

Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 2-level BAGUERA® ...